Form 8 (OPD) - Futura Medical
Futura Medical plc has amended its Form 8 (OPD) disclosure, originally released on 17 September 2026. As the offeree, the company reported no existing interests or short positions in its own ordinary shares as of 16 September 2026. However, the disclosure details that directors Alexander Duggan, Kenneth James, Andrew Unitt, and Roy Davis have agreed to subscribe for a total of 23,500,000 new shares at 0.2p each in a conditional placing. Additionally, connected advisers Benjamin Turner, James Pope, and their close relatives hold 21,749,999 ordinary shares and have warrants to subscribe for a significant number of new shares, including 163,625,000 at 0.2p and 53,750,001 conditional placing shares at the same price.
Select text to share a quote on X · sign in to keep highlights & notes in your FUM notes
The Form 8 (OPD) – Futura Medical’s announcement released on 17 September 2026 at 16:01 under RNS No 2677V has been amended.
Amendments are identified with an asterisk (*).
The full amended text is shown below.
FORM 8 (OPD)
PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER
Rules 8.1 and 8.2 of the Takeover Code (the “Code”)
KEY INFORMATION
| (a) Full name of discloser: | Futura Medical plc |
| (d) Is the discloser the offeror or the offeree? | OFFEREE |
| (e) Date position held: The latest practicable date prior to the disclosure | 16 September 2026 |
POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE
| Class of relevant security: | Ordinary shares of 0.2 pence each | |||
|---|---|---|---|---|
| Interests | Short positions | |||
| Number | % | Number | % | |
| (1) Relevant securities owned and/or controlled: | Nil | 0 | Nil | 0 |
| (2) Cash-settled derivatives: | Nil | 0 | Nil | 0 |
| TOTAL: | Nil | 0 | Nil | 0 |
All interests and all short positions should be disclosed.
Rights to subscribe for new securities
| Class of relevant security in relation to which subscription right exists: | None |
| Details, including nature of the rights concerned and relevant percentages: | None |
- POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE
Interests in Futura Medical plc's ordinary shares in which the directors of Futura Medical plc's are interested: Name Number of ordinary shares held Percentage of total issued share capital (to two decimal places) Alexander Duggan 5,000,000 0.78 Angela Hildreth 642,857 0.10 Kenneth James 799,501 0.13 Andrew Unitt 68,717 0.01 Roy Davis 40,295 0.01 *The following persons agreed to subscribe for a total of 23,500,000 new shares at a price of 0.2p per share in the Futura Medical plc Conditional Placing: Name Number of new ordinary shares to be subscribed for Alexander Duggan 12,500,000 Kenneth James 2,500,000 Andrew Unitt 6,000,000 Roy Davis 2,500,000 Options and awards held by directors of the Futura Medical plc: Name Share plan No of ordinary shares under options / awards Date of award Exercise price (per share) Vesting date Expiry date Alexander Duggan 26 LTIP 29,056,032 15 January 26 0.2p 15 January 2027 15 July 2027 Angela Hildreth 26 LTIP 11,622,413 15 January 2026 0.2p 15 January 2027* 15 July 2027 Angela Hildreth LTIP 1 472,340 7 December 22 0.2p 10 January 23 6 December 32 Angela Hildreth LTIP 2 1,267,742 10 October 23 0.2p 10 October 23 30 October 23 Angela Hildreth Tranche 16 200,000 17 September 19 31p 1 October 21 30 September 26 Angela Hildreth Tranche 17 200,000 21 September 20 15.5p 1 October 22 30 September 27 Angela Hildreth Tranche 18 264,000 5 October 21 37.90p 1 October 23 30 September 28 Angela Hildreth Tranche 20 132,000 14 September 22 45p 1 October 25 30 September 30 Angela Hildreth Tranche 21 264,000 6 April 23 43.60p 1 April 26 31 March 33 Angela Hildreth Tranche 22 280,000 19 April 24 35.5p 1 April 27 31 March 34 Ken James 26 LTIP 11,622,413 15 January 2026 0.2p 15 January 2027* 15 July 2027 Ken James LTIP 1 509,225 7 December 22 0.2p 10 January 23 6 December 32 Kenneth James LTIP 2 1,366,728 10 October 23 0.2p 10 October 23 30 October 23 Kenneth James Tranche 16 200,000 17 September 19 31p 1 October 21 30 September 26 Kenneth James Tranche 17 240,000 21 September 20 15.5p 1 October 22 30 September 27 Kenneth James Tranche 18 264,000 5 October 21 37.90p 1 October 23 30 September 28 Kenneth James Tranche 20 132,000 14 September 22 45p 1 October 25 30 September 30 Kenneth James Tranche 21 264,000 6 April 23 43.60p 1 April 26 31 March 33 Kenneth James Tranche 22 280,000 19 April 24 35.5p 1 April 27 31 March 34 Andrew Unitt N/A N/A N/A N/A N/A N/A Roy Davis N/A N/A N/A N/A N/A N/A *The extent to which awards under the 26 LTIP vest is subject to the achievement of performance targets with those options expiring 6 months from that date. Interests of connected advisers: Name Number of ordinary shares held Percentage of total issued share capital (to two decimal places) Benjamin Turner, James Pope & close relatives 21,749,999 3.40 Warrants (exercisable in return for one Ordinary Share each) held over Futura Medical plc's Ordinary Shares ("Warrants") by persons acting in concert (connected adviser) with Futura Medical plc Name Date of grant Expiry date Number of Warrants held Exercise Price per Warrant Benjamin Turner, James Pope & close relatives 4 December 2025 4 December 2030 *34,125,000 1p *2026 Warrants (exercisable in return for one Ordinary Share each) held over Futura Medical plc's Ordinary Shares ("Warrants") by persons acting in concert (connected adviser) with Futura Medical plc Name Date of grant Expiry date Number of Warrants held Exercise Price per Warrant Benjamin Turner, James Pope & close relatives 23 September 2026 23 September 2031 163,625,000 0.2p *Conditional Placing Shares to be subscribed for at a price of 0.2p per share by persons acting in concert (connected adviser) with Futura Medical plc Name Number of Conditional Placing Shares Benjamin Turner, James Pope & close relatives 53,750,001
- OTHER INFORMATION
- Indemnity and other dealing arrangements
None
- Agreements, arrangements or understandings relating to options or derivatives
None
Attachments
Are any Supplemental Forms attached?
| Supplemental Form 8 (Open Positions) | NO |
| Supplemental Form 8 (SBL) | NO |
| Date of disclosure: | 2 October 2026 |
Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.
The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.